Albatrellopsis confluens


Albatrellopsis confluens is a species of fungus in the family Albatrellaceae. It is commonly referred to as fused polypore. It is similar to Albatrellus ovinus, but bitter and with age tend to salmon color.

Taxonomy

The species was reclassified from genus Albatrellus to Albatrellopsis in 1993 based on morphological characteristics and phylogenetic analysis. Recent molecular phylogenetic analysis showed high sequence similarity with Albatrellopsis flettii and confirmed this reclassification.

Description

The cap is in diameter, hemispherical or irregularly circular. The surface color is cream or apricot with an orange tinge, sometimes also reddish-brown or ochre. It is flaky at the edges. The skin becomes cracked in the dry period. It usually occurs in clusters of fused fruit bodies up to across.
The hymenophore is made of tubes up to long, decurrent on the stem, white. The pores are very small and circular. The spore print is white. The spores are broadly ovate to almost spherical, colorless, smooth and measure 4.5–5 × 3–3.5 μm.
The stipe is long, wide, and not very distinct. It is central, eccentric or lateral. The colour is white, sometimes with an apricot, rusty tinge and spots.
The flesh is cream-coloured. The odour is weak and pleasant, the taste bitter.

Similar species

Distribution and habitat

A species widespread in Europe and North America, recorded also in Japan and on the Yorke Peninsula in Australia.
Albatrellopsis confluens is a saprotrophic fungus. It occurs sporadically in coniferous and mixed forests and most often found in mountain spruce forests. It grows on the ground, singly or in crowded clumps from July to October.

Edibility

The mushroom is edible when young, while old specimens are unpalatable and bitter. Due to its poor taste and rarity, picking is advised against.

Biochemistry

Albatrellopsis confluens is noted for its medicinal properties, particularly due to the presence of the bioactive compound grifolin. Studies have demonstrated that grifolin exhibits significant anticancer activity by inducing apoptosis and promoting cell cycle arrest, specifically in ovarian and human osteosarcoma cells. The compound achieves this by inactivating key signaling pathways, such as ERK1/2 and PI3K/AKT. Additionally, grifolin has been found to have anti-inflammatory and antioxidant properties.